ALK-inhibitor or RET-inhibitor + BNT116

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

ALK-inhibitor or RET-inhibitor + BNT116
Treatment and conditionWhere it standsTrials
ALK-inhibitor or RET-inhibitor + BNT116 for arthrogryposisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1